ABEO Annual Operating Profit
-$48.20 M
-$2.94 M-6.50%
31 December 2023
Summary:
As of January 23, 2025, ABEO annual operaing income is -$48.20 million, with the most recent change of -$2.94 million (-6.50%) on December 31, 2023. During the last 3 years, it has risen by +$304.00 thousand (+0.63%). ABEO annual operating profit is now -14234.90% below its all-time high of $341.00 thousand, reached on December 31, 1995.ABEO Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ABEO Quarterly Operating Profit
-$15.35 M
+$2.52 M+14.10%
30 September 2024
Summary:
As of January 23, 2025, ABEO quarterly operating income is -$15.35 million, with the most recent change of +$2.52 million (+14.10%) on September 30, 2024. Over the past year, it has dropped by -$2.14 million (-16.17%). ABEO quarterly operating profit is now -3392.92% below its all-time high of $466.00 thousand, reached on December 31, 2004.ABEO Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ABEO TTM Operating Profit
-$60.75 M
-$4.01 M-7.07%
30 September 2024
Summary:
As of January 23, 2025, ABEO TTM operating income is -$60.75 million, with the most recent change of -$4.01 million (-7.07%) on September 30, 2024. Over the past year, it has dropped by -$12.55 million (-26.03%). ABEO TTM operating profit is now -7503.00% below its all-time high of -$799.00 thousand, reached on March 31, 1999.ABEO TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ABEO Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -6.5% | -16.2% | -26.0% |
| 3 y3 years | +0.6% | -3.2% | -5.3% |
| 5 y5 years | +17.1% | +13.1% | +21.2% |
ABEO Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -6.5% | +16.0% | -63.6% | +14.1% | -41.7% | at low |
| 5 y | 5-year | -6.5% | +37.5% | -145.6% | +14.1% | -41.7% | +21.2% |
| alltime | all time | <-9999.0% | +37.5% | -3392.9% | +36.0% | -7503.0% | +22.8% |
Abeona Therapeutics Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$15.35 M(-14.1%) | -$60.75 M(+7.1%) |
| June 2024 | - | -$17.86 M(+24.7%) | -$56.74 M(+12.4%) |
| Mar 2024 | - | -$14.33 M(+8.5%) | -$50.49 M(+4.8%) |
| Dec 2023 | -$48.20 M(+6.5%) | -$13.21 M(+16.5%) | -$48.20 M(+2.6%) |
| Sept 2023 | - | -$11.33 M(-2.5%) | -$46.98 M(+4.3%) |
| June 2023 | - | -$11.62 M(-3.5%) | -$45.02 M(+5.0%) |
| Mar 2023 | - | -$12.04 M(+0.4%) | -$42.87 M(-5.3%) |
| Dec 2022 | -$45.26 M(-21.1%) | -$11.99 M(+27.8%) | -$45.26 M(-4.6%) |
| Sept 2022 | - | -$9.38 M(-0.9%) | -$47.46 M(-10.4%) |
| June 2022 | - | -$9.47 M(-34.4%) | -$52.95 M(-7.4%) |
| Mar 2022 | - | -$14.42 M(+1.7%) | -$57.20 M(-0.3%) |
| Dec 2021 | -$57.37 M(+18.3%) | -$14.19 M(-4.6%) | -$57.37 M(-0.5%) |
| Sept 2021 | - | -$14.87 M(+8.4%) | -$57.66 M(+17.6%) |
| June 2021 | - | -$13.71 M(-6.0%) | -$49.04 M(+2.6%) |
| Mar 2021 | - | -$14.60 M(+0.8%) | -$47.81 M(-1.4%) |
| Dec 2020 | -$48.50 M(-37.1%) | -$14.48 M(+131.8%) | -$48.50 M(-3.8%) |
| Sept 2020 | - | -$6.25 M(-49.9%) | -$50.44 M(-18.4%) |
| June 2020 | - | -$12.48 M(-18.4%) | -$61.84 M(-15.7%) |
| Mar 2020 | - | -$15.29 M(-6.8%) | -$73.33 M(-4.9%) |
| Dec 2019 | -$77.09 M(+32.5%) | -$16.41 M(-7.0%) | -$77.09 M(-2.0%) |
| Sept 2019 | - | -$17.65 M(-26.4%) | -$78.69 M(+0.9%) |
| June 2019 | - | -$23.98 M(+25.8%) | -$77.96 M(+17.2%) |
| Mar 2019 | - | -$19.05 M(+5.8%) | -$66.54 M(+14.4%) |
| Dec 2018 | -$58.17 M(+109.0%) | -$18.01 M(+6.5%) | -$58.17 M(+18.9%) |
| Sept 2018 | - | -$16.92 M(+34.7%) | -$48.91 M(+30.9%) |
| June 2018 | - | -$12.56 M(+17.5%) | -$37.35 M(+12.4%) |
| Mar 2018 | - | -$10.68 M(+22.1%) | -$33.23 M(+19.4%) |
| Dec 2017 | -$27.84 M(+16.6%) | -$8.75 M(+63.2%) | -$27.84 M(+11.7%) |
| Sept 2017 | - | -$5.36 M(-36.5%) | -$24.92 M(+0.8%) |
| June 2017 | - | -$8.44 M(+59.7%) | -$24.73 M(+7.5%) |
| Mar 2017 | - | -$5.28 M(-9.4%) | -$23.00 M(-3.7%) |
| Dec 2016 | -$23.88 M(+28.8%) | -$5.83 M(+12.7%) | -$23.88 M(-1.7%) |
| Sept 2016 | - | -$5.17 M(-22.9%) | -$24.30 M(-3.9%) |
| June 2016 | - | -$6.71 M(+9.0%) | -$25.29 M(+11.4%) |
| Mar 2016 | - | -$6.16 M(-1.5%) | -$22.70 M(+22.4%) |
| Dec 2015 | -$18.55 M(+492.3%) | -$6.25 M(+1.4%) | -$18.55 M(+45.3%) |
| Sept 2015 | - | -$6.16 M(+49.4%) | -$12.76 M(+76.5%) |
| June 2015 | - | -$4.13 M(+106.1%) | -$7.23 M(+90.0%) |
| Mar 2015 | - | -$2.00 M(+328.7%) | -$3.81 M(+21.5%) |
| Dec 2014 | -$3.13 M(-17.7%) | -$467.00 K(-26.2%) | -$3.13 M(-6.5%) |
| Sept 2014 | - | -$633.00 K(-10.0%) | -$3.35 M(-1.8%) |
| June 2014 | - | -$703.00 K(-47.1%) | -$3.41 M(-26.3%) |
| Mar 2014 | - | -$1.33 M(+94.2%) | -$4.63 M(+21.7%) |
| Dec 2013 | -$3.80 M(-11.9%) | -$684.00 K(-1.7%) | -$3.80 M(-12.3%) |
| Sept 2013 | - | -$696.00 K(-63.8%) | -$4.34 M(-5.7%) |
| June 2013 | - | -$1.92 M(+281.9%) | -$4.60 M(+11.4%) |
| Mar 2013 | - | -$503.00 K(-58.7%) | -$4.13 M(-4.3%) |
| Dec 2012 | -$4.32 M(-45.2%) | -$1.22 M(+27.5%) | -$4.32 M(-9.8%) |
| Sept 2012 | - | -$956.00 K(-34.2%) | -$4.79 M(-14.7%) |
| June 2012 | - | -$1.45 M(+110.7%) | -$5.62 M(-12.5%) |
| Mar 2012 | - | -$689.00 K(-59.2%) | -$6.42 M(-18.5%) |
| Dec 2011 | -$7.88 M | -$1.69 M(-5.3%) | -$7.88 M(-2.3%) |
| Sept 2011 | - | -$1.78 M(-20.8%) | -$8.06 M(-6.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2011 | - | -$2.25 M(+4.8%) | -$8.58 M(+3.8%) |
| Mar 2011 | - | -$2.15 M(+14.4%) | -$8.26 M(+6.5%) |
| Dec 2010 | -$7.76 M(-19.8%) | -$1.88 M(-18.2%) | -$7.76 M(+2.6%) |
| Sept 2010 | - | -$2.30 M(+18.4%) | -$7.56 M(-17.9%) |
| June 2010 | - | -$1.94 M(+18.1%) | -$9.21 M(-1.6%) |
| Mar 2010 | - | -$1.64 M(-2.5%) | -$9.36 M(-3.3%) |
| Dec 2009 | -$9.68 M(-68.5%) | -$1.69 M(-57.2%) | -$9.68 M(-0.5%) |
| Sept 2009 | - | -$3.94 M(+88.3%) | -$9.73 M(+0.7%) |
| June 2009 | - | -$2.09 M(+6.8%) | -$9.66 M(-0.6%) |
| Mar 2009 | - | -$1.96 M(+12.9%) | -$9.72 M(-47.0%) |
| Dec 2008 | -$30.73 M(+345.4%) | -$1.74 M(-55.2%) | -$18.32 M(-1.0%) |
| Sept 2008 | - | -$3.87 M(+79.6%) | -$18.50 M(+13.6%) |
| June 2008 | - | -$2.15 M(-79.6%) | -$16.28 M(+2.8%) |
| Mar 2008 | - | -$10.56 M(+452.5%) | -$15.84 M(+129.5%) |
| Dec 2007 | -$6.90 M(+33.3%) | -$1.91 M(+15.8%) | -$6.90 M(+14.4%) |
| Sept 2007 | - | -$1.65 M(-3.5%) | -$6.03 M(+7.0%) |
| June 2007 | - | -$1.71 M(+5.1%) | -$5.64 M(+6.3%) |
| Mar 2007 | - | -$1.63 M(+55.5%) | -$5.30 M(+2.5%) |
| Dec 2006 | -$5.17 M(-46.2%) | -$1.05 M(-16.7%) | -$5.17 M(-40.5%) |
| Sept 2006 | - | -$1.26 M(-8.6%) | -$8.70 M(+0.8%) |
| June 2006 | - | -$1.37 M(-8.3%) | -$8.63 M(-12.0%) |
| Mar 2006 | - | -$1.50 M(-67.2%) | -$9.81 M(+1.9%) |
| Dec 2005 | -$9.62 M(+60.3%) | -$4.57 M(+285.7%) | -$9.62 M(+109.9%) |
| Sept 2005 | - | -$1.19 M(-53.6%) | -$4.58 M(-18.5%) |
| June 2005 | - | -$2.55 M(+94.4%) | -$5.63 M(+7.2%) |
| Mar 2005 | - | -$1.31 M(-381.8%) | -$5.25 M(-12.5%) |
| Dec 2004 | -$6.00 M(+10.6%) | $466.00 K(-120.9%) | -$6.00 M(-1.0%) |
| Sept 2004 | - | -$2.23 M(+2.4%) | -$6.06 M(+4.9%) |
| June 2004 | - | -$2.18 M(+5.4%) | -$5.78 M(+9.1%) |
| Mar 2004 | - | -$2.06 M(-609.6%) | -$5.30 M(-2.4%) |
| Dec 2003 | -$5.43 M(-37.6%) | $405.00 K(-120.8%) | -$5.43 M(-32.0%) |
| Sept 2003 | - | -$1.94 M(+14.7%) | -$7.97 M(-8.4%) |
| June 2003 | - | -$1.69 M(-22.8%) | -$8.71 M(-4.6%) |
| Mar 2003 | - | -$2.19 M(+2.3%) | -$9.13 M(+5.0%) |
| Dec 2002 | -$8.70 M(+37.9%) | -$2.14 M(-19.9%) | -$8.70 M(+7.3%) |
| Sept 2002 | - | -$2.67 M(+26.3%) | -$8.11 M(+11.4%) |
| June 2002 | - | -$2.12 M(+20.1%) | -$7.28 M(+7.9%) |
| Mar 2002 | - | -$1.76 M(+13.7%) | -$6.74 M(+6.9%) |
| Dec 2001 | -$6.31 M(+4.1%) | -$1.55 M(-15.9%) | -$6.31 M(-3.8%) |
| Sept 2001 | - | -$1.84 M(+16.4%) | -$6.55 M(+5.7%) |
| June 2001 | - | -$1.58 M(+19.1%) | -$6.20 M(-1.3%) |
| Mar 2001 | - | -$1.33 M(-26.0%) | -$6.29 M(+3.8%) |
| Dec 2000 | -$6.06 M(+80.9%) | -$1.80 M(+20.4%) | -$6.06 M(+16.3%) |
| Sept 2000 | - | -$1.49 M(-10.4%) | -$5.21 M(+20.7%) |
| June 2000 | - | -$1.67 M(+51.5%) | -$4.32 M(+25.1%) |
| Mar 2000 | - | -$1.10 M(+15.8%) | -$3.45 M(+9.6%) |
| Dec 1999 | -$3.35 M(-4.3%) | -$950.00 K(+58.6%) | -$3.15 M(+43.2%) |
| Sept 1999 | - | -$599.00 K(-25.1%) | -$2.20 M(+37.5%) |
| June 1999 | - | -$800.00 K(+0.1%) | -$1.60 M(+100.1%) |
| Mar 1999 | - | -$799.00 K | -$799.00 K |
| Dec 1998 | -$3.50 M(-22.6%) | - | - |
| Dec 1997 | -$4.52 M(-61.0%) | - | - |
| Dec 1996 | -$11.61 M(-3505.6%) | - | - |
| Dec 1995 | $341.00 K | - | - |
FAQ
- What is Abeona Therapeutics annual operaing income?
- What is the all time high annual operating profit for Abeona Therapeutics?
- What is Abeona Therapeutics annual operating profit year-on-year change?
- What is Abeona Therapeutics quarterly operating income?
- What is the all time high quarterly operating profit for Abeona Therapeutics?
- What is Abeona Therapeutics quarterly operating profit year-on-year change?
- What is Abeona Therapeutics TTM operating income?
- What is the all time high TTM operating profit for Abeona Therapeutics?
- What is Abeona Therapeutics TTM operating profit year-on-year change?
What is Abeona Therapeutics annual operaing income?
The current annual operating profit of ABEO is -$48.20 M
What is the all time high annual operating profit for Abeona Therapeutics?
Abeona Therapeutics all-time high annual operaing income is $341.00 K
What is Abeona Therapeutics annual operating profit year-on-year change?
Over the past year, ABEO annual operaing income has changed by -$2.94 M (-6.50%)
What is Abeona Therapeutics quarterly operating income?
The current quarterly operating profit of ABEO is -$15.35 M
What is the all time high quarterly operating profit for Abeona Therapeutics?
Abeona Therapeutics all-time high quarterly operating income is $466.00 K
What is Abeona Therapeutics quarterly operating profit year-on-year change?
Over the past year, ABEO quarterly operating income has changed by -$2.14 M (-16.17%)
What is Abeona Therapeutics TTM operating income?
The current TTM operating profit of ABEO is -$60.75 M
What is the all time high TTM operating profit for Abeona Therapeutics?
Abeona Therapeutics all-time high TTM operating income is -$799.00 K
What is Abeona Therapeutics TTM operating profit year-on-year change?
Over the past year, ABEO TTM operating income has changed by -$12.55 M (-26.03%)